TrialCancer2025

Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trial.

Emanuela Palmerini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.